Unidare Pharmacueticals Private Limited - Company Profile

It is a paper private limited company based in Thane, Maharashtra, India, established in 2023.
2023 Thane, Maharashtra, India Active
Last Updated:
About Unidare Pharmacueticals Private Limited

Unidare Pharmacueticals Private Limited, a active private limited company, was established on 17 April 2023 in Thane, Maharashtra, India. Engaging in paper & paper products within the paper sector, it holds CIN: U21001PN2023PTC219577. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.

Its leadership includes Brajendra Narayan Singh (Director), Jyoti Kumari (Director), Himanshu Shekhar Tiwari (Director). It is based at C/O Rohini Kamlakar Patil, House No 864, Gala No 01, Patil Niwas, Opposite Jain Temple, Thane, Maharashtra, 400615.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U21001PN2023PTC219577

  • Registration Number

    219577

  • Incorporation Date

    17 April 2023

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Pune

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 2 Year, 10 Months
Company report

Unidare Pharmacueticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Unidare Pharmacueticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Unidare Pharmacueticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Brajendra Narayan Singh Director 17 Apr 2023 Current
Jyoti Kumari Director 17 Apr 2023 Current
Himanshu Shekhar Tiwari Director 17 Apr 2023 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Unidare Pharmacueticals.

Enhance accessibility to Unidare Pharmacueticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Unidare Pharmacueticals revenue growth over time
Unidare Pharmacueticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Unidare Pharmacueticals?

Unlock access to Unidare Pharmacueticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Unidare Pharmacueticals?

Unlock and access historical data on people associated with Unidare Pharmacueticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Unidare Pharmacueticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unidare Pharmacueticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Unidare Pharmacueticals
Recent Activity within the Organization
  • Director Appointment

    Progress on Brajendra Narayan Singh was appointed as a Director was appointed as a Director on 17 Apr 2023 & has been associated with this company since 2 years 10 months . was documented.

  • Director Appointment

    Progress on Jyoti Kumari was appointed as a Director was appointed as a Director on 17 Apr 2023 & has been associated with this company since 2 years 10 months . was documented.

  • Director Appointment

    Progress on Himanshu Shekhar Tiwari was appointed as a Director was appointed as a Director on 17 Apr 2023 & has been associated with this company since 2 years 10 months . was documented.

  • Company Incorporation

    Progress on Unidare Pharmacueticals Private Limited was registered on 17 Apr 2023 with Roc Pune & aged 2 years 10 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Unidare Pharmacueticals Private Limited?

The CIN of Unidare Pharmacueticals Private Limited is U21001PN2023PTC219577.

Where is Unidare Pharmacueticals Private Limited headquartered?

Unidare Pharmacueticals Private Limited is headquartered at C/O Rohini Kamlakar Patil, House No 864, Gala No 01, Patil Niwas, Opposite Jain Temple, Thane, Maharashtra, 400615.

When was Unidare Pharmacueticals Private Limited incorporated?

Unidare Pharmacueticals Private Limited was incorporated on 17 April 2023.

Who are the current directors of Unidare Pharmacueticals Private Limited?

The current directors of Unidare Pharmacueticals Private Limited are

What is the primary industry of Unidare Pharmacueticals Private Limited?

The primary industry of Unidare Pharmacueticals Private Limited is Paper.

Is Unidare Pharmacueticals Private Limited a listed company?

Unidare Pharmacueticals Private Limited is unlisted.

What is the capital structure of Unidare Pharmacueticals Private Limited?

The authorized capital of Unidare Pharmacueticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available